Rosenblatt lowered the firm’s price target on Harmonic (HLIT) to $16 from $18 and keeps a Buy rating on the shares. The company “blew away expectations” in Q3 and guided to continued strength in Q4, but cautionary comments about some potential customer delays in 2025 around the availability of unified DOCSIS 4.0 components “is going to put the stock right back into the penalty box,” the analyst tells investors in a research note. The firm, however, believes that over the next couple of quarters these supply issues can be solved and growth can resume.